Key Takeaway
Exogenous melatonin significantly decreases sleep onset latency, increases sleep efficiency, and increases total sleep duration with no evidence of tolerance or dependency.
Summary
This meta-analysis from MIT and other institutions examined 17 controlled studies to determine the effects of exogenous melatonin on sleep parameters. The study included prominent melatonin researcher Richard Wurtman among its authors.
The analysis provided strong evidence for melatonin's efficacy across multiple sleep parameters and importantly found no evidence of tolerance development or withdrawal effects with continued use.
Methods
- Meta-analysis of 17 controlled studies
- 284 subjects in melatonin groups, 273 in placebo groups
- Studies included single-dose and repeated administration
- Weighted mean differences calculated
- Subgroup analysis by study design
Key Results
- Sleep onset latency decreased by 4.0 minutes (p=0.001)
- Sleep efficiency increased by 2.2% (p=0.001)
- Total sleep duration increased by 12.8 minutes (p=0.001)
- Effects consistent in older and younger adults
- No evidence of tolerance with repeated use
- No withdrawal effects reported
- Larger effects in people with delayed sleep phase
Limitations
- Included studies with various doses and timing
- Some heterogeneity in study populations
- Limited long-term follow-up data
- Most studies in controlled laboratory settings
- Publication bias possible